What is ribociclib and how much does it cost?

Ribociclib, known in English asRibociclib, is an innovative anti-cancer drug that has shown significant effects in the treatment of breast cancer. It is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). By precisely blocking the activity of these kinases, ribociclib can effectively contain cancer cells in the first phase of the division cycle (G1 phase), thereby preventing further division and proliferation. This mechanism provides a powerful means to control the progression of breast cancer.

In clinical practice, ribociclib is widely used to treat postmenopausal patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Studies have shown that when used in combination with an aromatase inhibitor, ribociclib can significantly reduce the risk of disease progression and extend patients' progression-free survival. Its superior efficacy makes ribociclib an important treatment option for many breast cancer patients.

In addition, the medication regimen of ribociclib is relatively simple. It is usually taken orally once a day and taken continuously for 21 days and then stopped for 7 days, with 28 days as a complete medication cycle. This periodic medication pattern not only facilitates patient management, but also helps maintain a stable concentration of the drug in the body, thereby ensuring sustained therapeutic effects.

Currently, ribociclib has been launched in the country, with a price of approximately 8,000 yuan. At the same time, the original drug Ribociclib is also available in overseas markets. Ribociclib sold in Europe comes in two packaging specifications. The price of 200mg*21 tablets is about 22,000 yuan. In India, the price of the original version of ribociclib is about 3,000 yuan per box. These are the original versions of ribociclib, but the sales regions are different.

In general, ribociclib has brought new treatment hope to breast cancer patients with its unique anti-cancer mechanism and excellent clinical performance, and has become a shining pearl in the field of anti-cancer today.